PROVIDER FILE · The cost notebook

Maven Clinic GLP-1 Review: What the $39 First Month Leaves to Budget

Maven separates its GLP-1 membership from pharmacy charges. Its introductory price, prepaid options and medication minimums need to be read as different parts of the bill—not as an all-inclusive treatment price.

Maven Clinic’s $39 first month is an entry price for care, not a complete monthly GLP-1 budget. The company separately advertises medication starting prices, a $150 ongoing monthly membership and discounted membership rates that require prepayment. For a prospective patient, the important question is not simply which number appears largest on the page. It is which charges apply together, when they are collected and what remains outside the advertised package.

This documentary review examines Maven’s consumer GLP-1 offering through that cost lens, using sources consulted October 19, 2026. Maven describes virtual care focused on women’s metabolic and hormonal health, with clinical assessment, prescribing when appropriate and ongoing support. The pages document substantial pricing information, but they do not settle every enrollment, cancellation or pharmacy detail. Its employer-sponsored family benefits and separate hormone-care package also need to be kept apart from the self-pay GLP-1 membership.

At a glance

Introductory membership
$39 for the first month, followed by $150 per month on the monthly option; medication is separate.
Sources: [9]
Prepaid alternatives
$297 every three months, $534 every six months or $888 every 12 months, advertised as $99, $89 or $74 per month respectively.
Sources: [9]
Two billing channels
The membership covers prescribing-related visits and care; the pharmacy bills medication separately according to drug and dose.
Sources: [9]
Medication offering
Maven says it prescribes brand-name, FDA-approved GLP-1 medications and does not offer compounded formulations.
Sources: [10]
Refund boundary
Patients found clinically unsuitable for GLP-1 treatment may qualify for a refund; the consulted material does not establish an automatic refund or complete cancellation rules.
Sources: [9]

Start with the bill after the introductory month

Maven’s dedicated pricing page gives the clearest starting point: membership costs $39 for the first month and $150 per month afterward on the monthly option. It explicitly says medication is priced separately. The membership is described as covering the visits and care needed to obtain and continue a GLP-1 prescription, rather than purchasing the medicine itself. That distinction matters even when a medication advertisement appears nearby and uses the same monthly language.

The lower membership figures are optional prepaid alternatives, not mandatory upfront purchases for everyone. Maven advertises three months at an equivalent $99 per month, collected as $297 every three months; six months at $89 per month, collected as $534 every six months; and 12 months at $74 per month, collected as $888 every 12 months. Those billing periods describe membership charges, not a confirmed quantity of medication supplied.

Maven says the first month is always $39, including alongside its invitation to prepay for a lower rate. The consulted text does not explain exactly when that introductory month ends and a prepaid period begins, or when the larger charge is collected. Before selecting a plan, request a dated payment schedule. Our explanation of introductory payments versus advertised monthly prices helps frame that distinction without assuming the lowest displayed rate is the amount due today.

Advertised membership choices; medication costs are additional
OptionAdvertised membership priceCollection or timing detail
Introductory month$39First month; transition into prepaid billing is not fully explained
Monthly afterward$150 per monthMonthly payment option
Three-month prepayment$99 per month equivalent$297 billed every three months
Six-month prepayment$89 per month equivalent$534 billed every six months
12-month prepayment$74 per month equivalent$888 billed every 12 months
Sources: [9]

Medication prices are a separate, conditional quote

Maven’s medication table lists several distinct presentations. Wegovy pills start at $149 per month self-pay, while the Wegovy autoinjector pen starts at $199. Foundayo pills start at $149. Zepbound KwikPen starts at $299. Each of these entries also advertises pricing as low as $25 per month with qualifying insurance. These are starting amounts, not individualized quotes, and the company says medication costs depend on the product and dose.

The Ozempic pen entry needs particular attention: its advertised self-pay minimum is $199 per month, and the displayed 0.25 mg price is a new-patient introductory offer through December 31, 2026, followed by $349. That dose identifies the priced presentation, not a recommendation. Separately, the Zepbound vial entry starts at $299 self-pay but also carries the conflicting description “Autoinjector pen.” Confirm the exact presentation rather than treating that entry as unambiguous.

Some medication discounts also depend on a manufacturer’s refill window. Maven says certain medicines must be refilled within 45 days of the last order to retain the best available pricing. That is a commercial condition, not a delivery promise or a reason to change treatment independently. A useful quote should identify the medicine, presentation, applicable dose, pharmacy channel, introductory end date and any refill condition before the patient compares it with the membership charge.

Sources: [9] [4]

Insurance can affect the pharmacy bill, not the membership fee

Maven states that its GLP-1 membership fee is not covered by insurance. Medication coverage is a separate matter: the company offers insurance advocates who help prospective patients understand benefits and explore potential coverage before starting. If a medication is not covered, self-pay pricing is available. That assistance is useful, but the documentation does not turn an advertised insured minimum into a guarantee that a particular plan or prescription will qualify.

According to Maven, many insurers cover GLP-1 medications for type 2 diabetes, while coverage for weight management varies more. The broader point is consistent with NIDDK guidance that individual medication coverage must be checked with the plan. A patient should distinguish a benefits discussion from a confirmed pharmacy claim and ask what they would owe if coverage is denied, delayed or changes. The membership obligation remains a separate question.

Maven’s main site also describes certain family-care benefits as free for members covered through an employer or health plan. That wording should not be carried over to its consumer GLP-1 program, which the homepage labels self-pay. Its enterprise pricing page describes another arrangement altogether: a fixed cost per enrolled member, potentially varying with company size. Our guide to insurance and self-pay questions explains why those payment channels should be evaluated separately.

Sources: [9] [10] [7] [6] [2]

What the care fee includes—and where extra charges begin

The documented offering is broader than a prescription transaction. Maven describes side-effect management, personalized weight and metabolic insights, and follow-up through messages or scheduled video calls. Patients can track symptoms and progress, with that information visible to the care team. Its assessment also brings hormonal history and life stage into the consultation. These features explain what the membership is intended to buy, although they do not establish a guaranteed response time or continuous clinician availability.

Maven says the first nutrition and strength consultations are included, with additional visits available as care evolves. Elsewhere, it describes access to its full provider network as pay-as-you-go. Consequently, access to the network should not be read as unlimited visits with every professional at no additional charge. The consulted pages do not supply a complete fee schedule for additional consultations, laboratory work or services outside the initial team.

A pricing footnote narrows unlimited visits to the initial GLP-1 Care Team and allows separate charges for additional visits or services. It also leaves the team’s composition unfinished as “[xxx].” That is a material documentation gap because patients cannot tell precisely which professionals fall inside the unlimited allowance. Ask for the included team and extra-visit prices in writing; what a program price actually includes offers a useful framework for that conversation.

Sources: [5] [10] [9]

Assessment comes before a prescribing decision

Maven says its initial assessment asks about hormonal history, life stage and conditions such as PCOS or perimenopause. A licensed clinician reviews it before the first visit. Eligibility depends on factors including BMI, medical history and existing conditions, and some patients may need laboratory testing or previous medical records depending on their history and location. The consulted material does not publish a minimum age or specific BMI thresholds for this program.

These details make the advertised membership different from a guaranteed prescription purchase. Maven says that when GLP-1 treatment is not appropriate, it can help develop another plan shaped by the patient’s goals and history, potentially involving hormones or other options. That statement describes an alternative-care process, not a promise that another treatment will be prescribed or included at the same price. Any resulting change in services or charges needs its own explanation.

Availability also remains location-specific. Maven says services and prescribing vary with location, availability and applicable law, but the consulted pages do not identify the states or countries served by GLP-1 Care. The platform’s broader claim of services across more than 175 countries does not establish GLP-1 prescribing access in those places. Both enrollment and waitlist language appear, so neither immediate appointments nor an immediate treatment start can be assumed.

Sources: [5] [10] [4] [9] [7]

Follow the prescription through to the pharmacy

Maven says prescriptions are sent to the patient’s pharmacy, with direct shipment available for select medications. That is narrower than a promise that every medicine will arrive through a single home-delivery service. The consulted material does not name dispensing pharmacies, establish shipping charges or provide preparation, dispatch or arrival timelines. Before paying, patients should confirm who fills their specific prescription, who collects the medication payment and whom to contact if the pharmacy cannot complete the order.

Maven states that it prescribes only FDA-approved GLP-1 medications, naming semaglutide products Wegovy and Ozempic, tirzepatide as Zepbound, and orforglipron as Foundayo. It also says it does not offer compounded formulations. Those are provider statements about its offering, not an independent inspection of prescriptions or dispensing. FDA approval concerns a particular medication product; it does not mean that Maven itself has FDA approval as a clinic.

Delivery conditions matter independently of the membership price. FDA advises patients not to use an injectable GLP-1 drug that arrives warm or with insufficient refrigeration, and to contact the provider or dispensing pharmacy. That is general regulatory guidance, not evidence of a shipping problem at Maven. Because its pages do not establish a detailed cold-chain or replacement policy, patients receiving an injectable should clarify the delivery contact and problem-resolution process beforehand.

Sources: [10] [5] [9] [1]

Prepayment makes the missing exit terms more important

Maven says a patient whose clinician determines that GLP-1 treatment is unsuitable may qualify for a refund, directing readers to Payment Terms & Conditions. That is conditional language, not an automatic money-back promise. The complete linked payment terms were not available in the consulted text, so this review cannot establish the eligibility test, refund amount, claim procedure or processing schedule. It also cannot say whether an unused prepaid balance would be returned.

The same documentation gap applies to automatic renewal, cancellation notice requirements and how cancellation affects a prepaid period already purchased. A lower monthly equivalent can be attractive, but it should be weighed against those unresolved terms rather than treated as a flexible monthly subscription. Ask when cancellation takes effect, whether future charges stop and whether any money already collected is refundable. These are different questions, as our guide to subscription cancellation and refunds explains.

Clinical duration and billing duration should also remain separate. Maven describes treatment length as personal rather than setting one universal course. NIDDK similarly notes that duration depends on response and side effects and that obesity may require long-term care. A three-, six- or 12-month membership option therefore does not establish how long medication will be appropriate, how much will be dispensed or what financial adjustment follows a change in the care plan.

Sources: [9] [10] [2]

Keep the separate hormone package out of the GLP-1 comparison

Maven’s hormonal-health emphasis can make two distinct consumer offerings easy to conflate. Hormone Care Essentials is advertised at a one-time $150, without a subscription, including two 20-minute consultations and up to 20 messages. Additional visits and medication cost extra. That is not the same arrangement as the GLP-1 membership’s $150 ongoing monthly price. A shared number does not mean shared benefits, prescribing scope or renewal terms.

The hormone program describes options including birth control, vaginal estrogen, estrogen-only therapy, and estrogen with separately prescribed progesterone. It also lists nonhormonal possibilities such as SSRIs/SNRIs, gabapentin and incontinence medicines when appropriate. Its one-time service fee is not insurance-covered, although medications may be, and prescriptions go to the preferred pharmacy. Maven says virtual visits provide consultation and follow-up guidance, with direction toward in-person care or testing when needed.

For GLP-1 budgeting, the practical lesson is to identify the exact product being purchased before comparing fees. Neither the hormone package nor a free employer-sponsored family benefit establishes what is included in consumer GLP-1 Care. Likewise, Maven’s warning that prescriptions may be used off-label and carry serious risks should not be replaced by a price-based judgment about suitability. NIDDK recommends discussing benefits, side effects, other medicines, health history and costs with the treating clinician.

Sources: [3] [8] [7] [9] [2]

Questions & answers

Does Maven’s $39 first month include the medication?

No. The $39 is the introductory membership fee. Maven says the pharmacy bills medication separately based on the drug and dose. The monthly membership becomes $150 afterward unless a prepaid alternative is selected. Request separate membership and pharmacy quotes, including when each payment is due; the advertised medication minimum is not a complete treatment price.

Sources: [9]
Can I pay $74 each month instead of prepaying?

The documented $74 figure is a monthly equivalent for a $888 payment billed every 12 months. Maven separately offers monthly payment at $150 after the introductory month. It also advertises $297 every three months and $534 every six months. The precise timing of the first prepaid charge relative to the $39 introductory month remains unclear in the consulted text.

Sources: [9]
Will insurance pay for Maven GLP-1 Care?

Maven says insurance does not cover its GLP-1 membership fee. A prescribed medication may have coverage, depending on the plan and prescription. Insurance advocates can help explore benefits before starting, but the advertised $25 medication minimum is conditional. Ask for confirmation of your own pharmacy cost and the self-pay alternative rather than assuming the membership or medication will be covered.

Sources: [9] [4]
Are nutrition visits and all specialist appointments included?

Maven includes the first nutrition and strength consultations. It describes wider provider-network access as pay-as-you-go, and its unlimited-visit footnote applies only to the initial GLP-1 team. That footnote does not finish identifying the team’s members. Obtain the specific included roles, visit limits and prices for further consultations before treating the membership as an unlimited multidisciplinary package.

Sources: [10] [5] [9]
Does Maven ship every GLP-1 prescription to my home?

No universal home-delivery arrangement is documented. Maven says it sends prescriptions to the patient’s pharmacy or ships select medications directly. The consulted pages do not establish named dispensing pharmacies, shipping costs or arrival times. Confirm the arrangement for your exact medicine and location, including which organization handles payment, delivery questions and any problem with the received product.

Sources: [5] [9]
Will I get my money back if GLP-1 treatment is not appropriate?

Possibly, but Maven does not promise an automatic refund in the consulted material. It says patients may qualify if their clinician determines GLP-1s are not a fit and refers to separate payment terms. Those complete terms were not available here. Before paying, request the refund criteria, covered charges, procedure and treatment of any prepaid membership balance.

Sources: [9]

Our assessment

Maven documents a recognizable care offering and more pricing detail than a single starting-at advertisement: a distinct membership, optional prepaid rates, product-specific medication minimums and insurance-navigation support. The first nutrition and strength consultations also give the service a documented scope beyond prescribing. The weaknesses are financially consequential: incomplete cancellation and refund documentation, unclear introductory-to-prepaid timing, unspecified extra-service charges and an unfinished definition of the unlimited-care team. Maven is most fairly evaluated through a written, location-specific quote that separates membership, medication and additional services. The lowest monthly equivalent alone is not enough to judge the commitment.

Sources & documentation

Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.

  1. FDA concerns with unapproved GLP-1 drugs used for weight loss ↗
  2. NIDDK: prescription medications for overweight and obesity ↗
  3. Maven Clinic — hormone care/pricing ↗
  4. Maven Clinic — glp 1 care ↗
  5. Maven Clinic — glp 1 care/how it works ↗
  6. Maven Clinic — pricing ↗
  7. Maven Clinic — official website ↗
  8. Maven Clinic — hormone care/faq ↗
  9. Maven Clinic — glp 1 care/pricing ↗
  10. Maven Clinic — glp 1 care/faq ↗

Continue reading